JBC

HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


Originally published In Press as doi:10.1074/jbc.M101823200 on August 2, 2001

J. Biol. Chem., Vol. 276, Issue 40, 37215-37222, October 5, 2001
This Article
Right arrow Abstract Freely available
Right arrow Full Text (PDF)
Right arrow All Versions of this Article:
276/40/37215    most recent
M101823200v1
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Buhler, C.
Right arrow Articles by Forterre, P.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Buhler, C.
Right arrow Articles by Forterre, P.
Social Bookmarking
 Add to CiteULike   Add to Complore   Add to Connotea   Add to Del.icio.us   Add to Digg   Add to Reddit   Add to Technorati  
What's this?

DNA Topoisomerase VI Generates ATP-dependent Double-strand Breaks with Two-nucleotide Overhangs*

Cyril BuhlerDagger §, Joyce H. G. Lebbink, Chantal BocsDagger , Rudolf Ladenstein, and Patrick ForterreDagger

From the Dagger  Institut de Génétique et Microbiologie, CNRS UMR 8621, Bât 409, Université Paris-Sud, 91405, Orsay Cedex, France and the  Department of Biosciences, Karolinska Institute, S-14157 Huddinge, Sweden

Received for publication, February 28, 2001, and in revised form, August 2, 2001


    ABSTRACT
TOP
ABSTRACT
INTRODUCTION
EXPERIMENTAL PROCEDURES
RESULTS
DISCUSSION
REFERENCES

A key step in the DNA transport by type II DNA topoisomerase is the formation of a double-strand break with the enzyme being covalently linked to the broken DNA ends (referred to as the cleavage complex). In the present study, we have analyzed the formation and structure of the cleavage complex catalyzed by Sufolobus shibatae DNA topoisomerase VI (topoVI), a member of the recently described type IIB DNA topoisomerase family. A purification procedure of a fully soluble recombinant topoVI was developed by expressing both subunits simultaneously in Escherichia coli. Using this recombinant enzyme, we observed that the formation of the double-strand breaks on supercoiled or linear DNA is strictly dependent on the presence of ATP or AMP-PNP. This result suggests that ATP binding is required to stabilize an enzyme conformation able to cleave the DNA backbone. The structure of cleavage complexes on a linear DNA fragment have been analyzed at the nucleotide level. Similarly to other type II DNA topoisomerases, topoVI is covalently attached to the 5'-ends of the broken DNA. However, sequence analysis of the double-strand breaks revealed that they are all characterized by staggered two-nucleotide long 5' overhangs, contrasting with the four-base staggered double-strand breaks catalyzed by type IIA DNA topoisomerases. While no clear consensus sequences surrounding the cleavage sites could be described, interestingly A and T nucleotides are highly represented on the 5' extensions, giving a first insight on the preferred sequences recognized by this type II DNA topoisomerase.


    INTRODUCTION
TOP
ABSTRACT
INTRODUCTION
EXPERIMENTAL PROCEDURES
RESULTS
DISCUSSION
REFERENCES

Type II DNA topoisomerases are ubiquitous enzymes that catalyze the ATP-dependent transport of one DNA duplex through a second DNA segment via a transient double-strand break (1). This ability to modulate the topological state of DNA is essential in major biological processes such as replication, recombination, and transcription (2). Until recently, these enzymes were thought to form a single family of homologous proteins. The discovery of DNA topoisomerase VI (topoVI)1 in hyperthermophilic archaea has modified this classification. Type II DNA topoisomerases are now subdivided into two subfamilies, type IIA and IIB DNA topoisomerases (Fig. 1) (3).


View larger version (20K):
[in this window]
[in a new window]
 
Fig. 1.   Schematic alignment of amino acid sequences of type II DNA topoisomerases and Spo11 protein. Numbers refer to amino acids of S. cerevisiae topoII, E. coli DNA gyrase, S. shibatae DNA topoVI, and S. cerevisiae Spo11. Solid boxes correspond to homologous regions within type II A enzymes and between topoVI A subunit and Spo11. Gray boxes correspond to the Rossman fold-like domain described in yeast topoII (4) and M. jannashii topoVI A subunit structures (21). CAP corresponds to a fold similar to the DNA-binding domain of E. coli catabolite activator protein containing the active site tyrosine (Y*) (Tyr783) of yeast topoII (36) and Spo11 protein (Tyr135) (3). Vertical bars correspond to conserved motifs present in the ATP binding/hydrolysis domain of both subfamilies (3). The loop in GyrB corresponds to an insertion found in some gamma  proteobacteria. ATPase and B' refers to the proteolytic domains of the GyrB subunit (17, 18). A' corresponds to the DNA breakage-reunion domain of type IIA enzymes.

The type IIA subfamily contains three cellular representatives: eucaryotic DNA topoisomerase II (topoII), bacterial DNA gyrase, and DNA topoisomerase IV (topoIV). DNA gyrase and topoIV are heterotetramers composed of two subunits GyrA and GyrB, and ParC and ParE, respectively, while the eucaryotic enzyme is a homodimer. Despite this difference in quaternary structure, protein sequences comparison revealed that GyrB and ParE subunits are homologous to the N-terminal part of the eucaryotic enzyme while GyrA and ParC are homologous to the C-terminal half. These similarities were further confirmed by structural analysis of several fragments of Saccharomyces cerevisiae DNA topoII and Escherichia coli DNA gyrase (4-7).

Archaeal topoVI is the prototype of the recently described type IIB DNA topoisomerase subfamily (3). This enzyme was first characterized from the hyperthermophilic archaeon Sulfolobus shibatae (8) and further identified in other archaeal species (see below). Like bacterial type II DNA topoisomerases, topoVI is a heterotetramer composed of two subunits, A and B, with molecular masses of 45 and 60 kDa, respectively. This enzyme is able to decatenate intertwined DNA and to relax both positively or negatively supercoiled DNA in the presence of ATP and divalent cations. These reactions, shared with the type II DNA topoisomerases implicated in chromosome segregation (i.e. eucaryotic topoII and bacterial topoIV), suggest that topoVI is the enzyme responsible for chromosome decatenation at the end of the replication in archaeal cells.

Surprisingly, initial sequence analysis of the genes encoding the two subunits of the S. shibatae enzyme revealed no evident similarities with classical type II DNA topoisomerases (3), apart from a few amino acids of the ATP binding/hydrolysis domain of type IIA DNA topoisomerases located near the N terminus of the topoVI B subunit. These conserved residues, which are distributed into three small motifs, are key elements of an ATP binding fold (referred to as the Bergerat fold) present in three other protein families: the heat-shock proteins of the Hsp90 family, the mismatch repair proteins of the MutL family, and a histidine kinase family (3, 9). Further analysis of the topoVI B subunit sequences by protein secondary structure prediction suggests that the first 215 residues adopt a similar fold.2

Whereas topoVI A subunits are not homologous to the cleavage domains of type IIA DNA topoisomerases (referred to as the A' domain in Fig. 1), significant similarities with the eucaryotic proteins, Spo11 from S. cerevisiae, Rec12 from Schizosaccharomyces pombe, and a putative Spo11 homolog in Caenorhabditis elegans have been described (3). SPO11 is one of the essential genes involved in the initiation of meiotic recombination (10, 11). Two different studies have clearly identified Spo11 as the protein responsible for the double-strand breaks that initiate meiotic recombination in S. cerevisiae. Site-directed mutagenesis on Spo11, of the only conserved tyrosine (Tyr135) between archaeal topoVI and eucaryotic Spo11 proteins, abolishes double-strand breaks formation (3). In parallel, a covalent attachment of S. cerevisiae Spo11 to the 5'-ends of these double-strand breaks via a phosphotyrosine linkage has been described (12). Furthermore, these results suggest strongly that the conserved tyrosine is also directly implicated in the transient DNA cleavage catalyzed by archaeal topoVI (3).

The growing number of fully archaeal sequenced genomes revealed that topoVI is not restricted to hyperthermophilic archaea but is widely represented in the archaeal domain. Noteworthy, top6a and top6b genes have been identified in the complete genome sequence of the mesophilic strain Halobacterium sp. NRC-1 (13). The topoVI A subunit homolog, Spo11, is also widespread in eucaryotes and has been identified in mouse, human, and plants (14, 15). The situation in plants is particularly striking since three Spo11 homologs are present in the Arabidopsis thaliana genome (16). Furthermore, the recent identification of a topoVI B subunit homolog in this organism raises the possibility of a bona fide topoVI in plants (GenBankTM accession numbers AB025629 and BAB02486). However, no coding sequence similar to the archaeal top6b gene has been identified in other completely sequenced eucaryotic genomes.

While the DNA cleavage by type IIA topoisomerases is also ultimately performed by the active tyrosine in the breakage-reunion domain (marked A' in Fig. 1), several studies have highlighted the requirement of the B' domain in the DNA cleavage reaction (4, 17, 18). The central portion of the B' domain is an alpha -beta structure that resembles the "Rossman fold," present in a variety of metal-binding phosphotransfer proteins, including nucleases, topoisomerases, and response regulators (19). Secondary structure predictions suggested that topoVI also contains a Rossman fold located, however, on the A subunit, instead of the B subunit, as in the case of Type IIA enzymes. (Fig. 1) (20). This prediction has been confirmed with the resolution of the cristal structure of the archaeal Methanoccocus jannashii topoVI A subunit (spanning residues 69-369 and referred to as TopoVI-A' fragment) (21). This structural analysis has shown that the Rossman-fold like domain of topoVI lies next to a CAP-like domain,3 giving an overall structure unique among type II DNA topoisomerases, and confirming that topoVI belongs to a new family of type II DNA topoisomerases. This study has also revealed the presence of a Mg2+ ion within the Rossman-fold domain, supporting the idea of a metal-assisted cleavage reaction by type II DNA topoisomerases (21, 22).

Therefore, all the catalytic domains (Rossman-fold and CAP) known to be involved in the DNA cleavage reaction by type IIA DNA topoisomerases are located whithin the same subunit for both topoVI A subunit and Spo11 protein. This particular organization could suggest that DNA cleavage is performed without the help of an additional protein. Hence this would explain the absence of a topoVI B subunit homolog in most eucaryotes, suggesting that Spo11 can cleave DNA by itself at the onset of the meiotic recombination. However, we failed to detect DNA cleavage using S. shibatae topoVI A subunit alone, while recombinant S. shibatae topoVI reconstituted from both subunits separately overexpressed in E. coli generates double-strand breaks (23). Furthermore, eucaryotic Spo11 proteins have not yet been purified, precluding the possibility to test their ability to perform DNA cleavage in the absence of a companion protein.

To further analyze the formation of the double-strand breaks catalyzed by type IIB DNA topoisomerase, we have overproduced and purified a new recombinant topoVI in E. coli. Cloning both S. shibatae topoVI subunits in the same expression vector results in the overproduction of a soluble and active heterotetrameric enzyme. Analysis of the DNA cleavage reaction on supercoiled or linear DNA reveals a strict dependence on ATP binding, contrasting with DNA cleavages catalyzed by type IIA DNA topoisomerases (24-26).

We have also analyzed the structure of topoVI double-strand breaks on a 529-bp linear fragment. We observed that, similarly to type IIA DNA topoisomerases and S. cerevisiae Spo11 protein (12, 27), topoVI is covalently attached to the 5'-ends of the cleaved DNA. Characterization of several double-strand breaks at the nucleotide level reveals unusual features. All breaks generated have staggered two-nucleotide overhangs, contrasting with the four-base overhangs known for type IIA DNA topoisomerase (25, 26). Moreover, the 5' overhangs are mainly composed of the nucleotides A and T, giving the first insight of a consensus sequence recognition for this particular type II DNA topoisomerase.

    EXPERIMENTAL PROCEDURES
TOP
ABSTRACT
INTRODUCTION
EXPERIMENTAL PROCEDURES
RESULTS
DISCUSSION
REFERENCES

Materials-- The phosphocellulose P-11 was obtained from Whatman. Polyethylenimine, ATP, AMP-PNP, phenylmethylsulfonyl fluoride, and protein molecular weight markers were purchased from Sigma. Leupeptin and pepstatin A were purchased from Roche Molecular Biochemicals. Sephacryl S300 from Amersham Pharmacia Biotech. Sequagel-6 from National Diagnostic (Hessle, United Kingdom). [gamma -32P]ATP, [gamma -33P]ATP, and [alpha -32P]dATP from Amersham Pharmacia Biotech. The pair of DNA oligonucleotides, seqEcoRI and seqScaI, used for the amplification of a 529-bp pBR322 (encompassing EcoRI and ScaI restriction sites), 5'-CATGAGAATTCTTGAAGACGAAAGGGCCTC-3' and 5'-GTGAGTACTCAACCAAGTCATTCTGAG-3', were purchased from MWG Biotech (Ebersberg, Germany). Sequencing reactions were performed using the fmol DNA sequencing system from Promega (Madison, WI).

Enzymes-- Proteinase K, restriction enzymes, T4 polynucleotide kinase, E. coli DNA polymerase I Klenow fragment, and Tli DNA polymerase were purchased from Promega. T4 DNA polymerase and DNA ligase were purchased from New England Biolabs (Beverly, MA). Shrimp alkaline phosphatase was purchased from Roche Molecular Biochemicals.

Construction of pET3btop6BA Expression Vector-- The pET3btop6BA expression vector was constructed from plasmids pET3b-SsuB and pET25-SsuA (23). pET3b-SsuB was digested with BamHI restriction enzyme and the sticky ends were made blunt using T4 DNA polymerase. pET25-SsuA plasmid was digested with XbaI and BamHI. The fragment containing translation initiation signals and the gene encoding the A subunit was purified and made blunt with T4 DNA polymerase. This DNA fragment was then ligated into the linearized pET3b-SsuB vector. Clones containing the A subunit gene in the proper orientation were identified by restriction analysis.

Overexpression and Purification of Recombinant DNA Topoisomerase VI-- E. coli cells Bl21(DE3) were transformed with the plasmids pET3btop6BA and pUBS520 (a plasmid expressing rare Arg tRNAs that read AGG and AGA codons). Cells were grown at 37 °C in 0.5 liter of LB medium supplemented with 100 µg/ml ampicillin and 50 µg/ml kanamycin until A600 reached 0.5. Isopropyl-beta -D-thiogalactopyranoside (200 µM) was then added to the culture and cells were further grown for 2 h at 37 °C. Unless stated otherwise all enzyme purification steps were conducted at 4 °C. Cells were harvested by centrifugation and resuspended in buffer A (HEPES-NaOH, 20 mM; pH 7.5, KCl, 1 M; DTT, 1 mM; EDTA, 1 mM; EGTA, 1 mM; phenylmethylsulfonyl fluoride, 1 mM; 1 µg/ml leupeptin; and 1 µg/ml pepstatin). Cells were broken by sonication and the resulting solution was centrifuged at 15,000 × g for 15 min. The clarified lysate was then heated 15 min at 65 °C and centrifuged at 20,000 × g for 15 min. Nucleic acids were precipitated by slow addition of polyethylenimine with continuous stirring to a final concentration of 0.1%. After 15 min of additional stirring, the solution was centrifuged at 20,000 × g for 1 h. Proteins were precipitated by addition of ammonium sulfate to a final concentration of 70% saturation and centrifuged at 10,000 × g for 1 h. Precipitated proteins were dissolved in 400 ml of buffer B (HEPES-NaOH, 20 mM; pH 7.5, DTT, 1 mM; KCl, 50 mM) and adsorbed onto a 1-ml phosphocellulose column equilibrated with buffer B. The column was washed with 15 ml of buffer B and subjected to a 20-ml linear gradient of 50-800 mM KCl in buffer B. Fractions were pooled and passed over a Sephacryl S300 gel-filtration column (Amersham Pharmacia Biotech) equilibrated with buffer C (HEPES-NaOH, 20 mM; pH 7.5, DTT, 1 mM; KCl, 350 mM). Peak fractions were pooled and stored at -80 °C. One unit of topoVI is defined as the amount of enzyme required to relax 50 ng of pBR322 in 4 min at 75 °C under optimal conditions: 20 mM HEPES-NaOH, pH 7.5, 1 mM DTT, 0.1 mM Na2EDTA, 1 mM ATP, 40-60 mM KCl, and 10 mM MgCl2.

Labeling of pBR322 DNA-- 10 µg of pBR322 was first digested with EcoRI restriction enzyme. This linearized DNA was labeled either at its 5'-ends with 32P by T4 DNA polynucleotide kinase and [gamma -32P]ATP or by filling-in its recessed 3'-ends using E. coli DNA polymerase Klenow fragment and [alpha -32P]dATP and dTTP. To generate singly end-labeled DNA, these fragments were digested with the restriction enzyme ScaI producing two DNA fragments of 515 and 3848 bp. These DNA fragments were separated on a 1% agarose gel electrophoresis and purified using the QIAquick gel extraction kit from Qiagen (Valencia, CA).

Cleavage of a Negatively Supercoiled DNA by DNA Topoisomerase VI-- The standard cleavage assay (20 µl) contains 20 mM HEPES-NaOH, pH 7.5, 1 mM DTT, 0.1 mM Na2EDTA, 1 mM ATP or AMP-PNP, 50 mM KCl, 10 mM MgCl2 or CaCl2, 25 nM topoVI, and 0.9 nM (50 ng) negatively supercoiled pBR322. Samples were incubated at 75 °C for 4 min and stopped by addition of 2 µl of a 10% SDS (v/v) solution. 2 µl of a 1 mg/ml Proteinase K solution were then added and samples were further incubated at 55 °C for 1 h. 5 µl of loading buffer (30% sucrose, 0.25% bromphenol blue, 0.25% xylene cyanol) were added. Samples were loaded on a 1% agarose gel and subjected to electrophoresis in TBE buffer (100 mM Tris borate, pH 8, 3.2 mM EDTA) at 1 V/cm for 12 h. DNA was visualized by ethidium bromide staining at 1 µg/ml.

Distribution of the Double-strand Breaks on pBR322-- Reaction mixtures were identical to those described above for the cleavage of a negatively supercoiled DNA, except that 1 nM (55 ng) of the 3848-bp DNA fragment or 3 nM (20 ng) of the 515-bp DNA fragment, singly labeled (see above), were used as substrates. For the analysis of the distribution of double-strand breaks on the large fragment, 5 µl of loading buffer were added and samples were subjected to electrophoresis on a 1% agarose gel in TBE buffer at 5 V/cm for 2 h. For the analysis of the distribution of double-strand breaks on the small fragment, 5 µl of loading buffer were added and the samples were loaded on a 10% nondenaturing polyacrylamide gel (10% acrylamide, 37:1 acrylamide/bisacrylamide), and subjected to electrophoresis in TBE buffer at 20 V/cm for 2 h. Gels were dried on Whatmann No. 3MM paper sheets and visualized using a PhosphorImager (Molecular Dynamics, Sunnyvale, CA) and ImageQuant software.

Analysis of the Covalent Attachment of DNA Topoisomerase VI to the Double-strand Breaks-- 15 ng (4 nM) of the small pBR322 fragment, singly labeled at its 5'- or 3'-end with 32P (see above), was used in the standard cleavage assay. Reactions were stopped by addition of 2 µl of a 10% SDS (v/v) solution and samples were further treated or not with Proteinase K at a final concentration of 100 µg/ml. Products were analyzed by electrophoresis onto a DNA sequencing gel (8% polyacrylamide, 37:1 acrylamide/bisacrylamide), containing 7 M urea in TBE buffer. After 1 h migration at 2500 V (45 watts), the gel was dried and analyzed as before.

Sequence Analysis of DNA Topoisomerase VI DNA Cleavage Sites-- A 529-bp fragment, spanning the region between the EcoRI and ScaI sites of pBR322, was amplified by PCR using Tli DNA polymerase and the primers seqEcoRI and seqScaI. Amplified DNA was purified using QIAquick gel extraction kit. The DNA was then labeled at its 5'-ends using T4 polynucleotide kinase and [gamma -33P]ATP. The kinase was eliminated using micropure EZ (Amicon) and the purified DNA was digested either with ScaI or EcoRI restriction enzymes to generate singly end labeled DNA fragments (named upper and lower strand, respectively). DNA was finally purified using micropure EZ and resuspended into 10 mM Tris, pH 8.5. 40 ng of each labeled DNA were used in a standard cleavage assay in the presence of 1 mM AMP-PNP, 10 mM CaCl2, and 25 nM recombinant topoVI. After 4 min incubation at 75 °C, reactions were stopped with 1% (v/v) SDS, and 0.1 mg/ml Proteinase K (v/v) was added. Samples were incubated at 55 °C for 1 h and purified by phenol/chloroform extraction and ethanol precipitation. DNA were resuspended in 10 mM Tris, pH 8.5, and an equal volume of a loading buffer (95% formamide, 0.25% bromphenol blue, 0.25% xylene cyanol). In parallel, similar purifications of the topoVI-cleaved DNA were performed and further incubated with E. coli DNA polymerase I Klenow fragment and each dNTP as described by the manufacturer. Reactions were stopped by heating at 75 °C for 10 min before adding the loading buffer. The position of the 3'-ends of topoVI cleavage sites on both strands were determined by an enzymatic sequencing approach: the length of these fragments were determined by comparison with the enzymatic sequencing of the initial DNA substrate using the primer seqEcoRI or seqScaI. TopoVI cleavage products were loaded on a 6% sequencing gel (6% polyacrylamide, 19:1 acrylamide/bisacrylamide, containing 7 M urea), along with the sequencing reactions products. Electrophoresis were performed at 2500 V (45 watts) in TBE buffer with different migration times to precisely map the topoVI induced DNA breaks. Gels were dried and analyzed as before.

Protein Analysis-- Polypeptides were analyzed by SDS-polyacrylamide gel electrophoresis and visualized by Coomassie Blue dye staining. Protein concentrations were estimated by Bradford assay using bovine serum albumin as a standard (28).

    RESULTS
TOP
ABSTRACT
INTRODUCTION
EXPERIMENTAL PROCEDURES
RESULTS
DISCUSSION
REFERENCES

Expression and Purification of Recombinant DNA Topoisomerase VI-- We have previously constructed the plasmids pET3b-SsuB and pET25-SsuA for the expression of both topoVI subunits separately in E. coli (23). These plasmids were used as starting materials for the construction of the pET3btop6BA expression vector (see "Experimental Procedures"). The top6a gene and translational initiation signals were subcloned behind the top6b gene from the pET3bSsuB plasmid. The resulting vector contains both top6 genes under the same T7 promoter. Isopropyl-beta -D-thiogalactopyranoside induction results in the production of significant amounts of two polypeptides with apparent molecular masses of 45 and 60 kDa, consistent with the sizes of topoVI A and B subunits, respectively (Fig. 2, lane 3). Noteworthy, both overexpressed subunits are now present in the soluble protein fraction (Fig. 2, lane 4) whereas the expression of the A subunit alone in E. coli resulted in the production of an insoluble polypeptide (23). A purification scheme was developed based on the thermostability expected for S. shibatae topoVI and its heterotetrameric state. Fractions were analyzed by SDS-polyacrylamide gel electrophoresis (Fig. 2, lanes 4-8). As a final step, the heterotetrameric form of the recombinant enzyme was selected on a Sephacryl S300 gel filtration column. This purification procedure yielded 0.7 mg of recombinant topoVI from 500 ml of culture, with an estimated purity of about 90%. The estimated specific activity (7 × 104 units/mg of protein) is consistent with the specific activity of the native enzyme (8).


View larger version (78K):
[in this window]
[in a new window]
 
Fig. 2.   SDS-polyacrylamide gel electrophoresis of recombinant topoisomerase VI expression and purification fractions. Lane 1, molecular weight standards; lanes 2 and 3, E. coli crude extracts before and after 2 h isopropyl-beta -D-thiogalactopyranoside induction, respectively; lane 4, soluble fraction from the induced cell extract; lane 5, soluble heated fraction; lane 6, polyethylenimine supernatant; lane 7, phosphocellulose pool; lane 8, purified topoVI from S300 gel filtration column. After electrophoresis, the gel was stained with Coomassie Brilliant Blue.

ATP Binding Is Required for DNA Topoisomerase VI Induced DNA Cleavage-- The amounts of nicked or linear DNA molecules produced by this new recombinant enzyme, in the presence of calcium or magnesium cations and the cofactors ATP or AMP-PNP, were analyzed by agarose gel electrophoresis after standard cleavage assay (Fig. 3). TopoVI relaxes a negatively supercoiled DNA only in the presence of ATP and Mg2+ (Fig. 3, lane 3). When ATP is substituted by its nonhydrolyzable analog AMP-PNP, the enzyme generates important nicked and linear DNA products, indicating that SDS treatment efficiently traps the cleavage complexes (Fig. 3, lane 4). However, in the absence of AMP-PNP, no cleavage was observed (Fig. 3, lane 2). When Mg2+ is substituted by Ca2+, topoVI linearizes nearly all the supercoiled plasmid, in contrast to type IIA enzymes which produce a mixture of single- and double-strand breaks (29, 30). Ca2+-dependent DNA cleavage by S. shibatae topoVI also requires the presence of ATP or AMP-PNP (Fig. 3, compare lane 6 with lanes 7 and 8). Since this new recombinant enzyme generates important DNA breaks, this result shows a direct involvement of ATP binding in the DNA cleavage reaction, contrasting with the same reaction catalyzed by type IIA DNA topoisomerases (25, 26). Similar results were obtained in the presence of 30 and 80 mM KCl with no variations in quality or quantity of DNA products, except a diminution of the relaxation activity at 80 mM KCl (data not shown). In the following experiments, cleavage reactions were performed in optimal conditions, i.e. 10 mM CaCl2 and 1 mM AMP-PNP.


View larger version (83K):
[in this window]
[in a new window]
 
Fig. 3.   ATP requirement for calcium and magnesium-promoted DNA cleavage of a negatively supercoiled DNA by topoisomerase VI. 50 ng of negatively supercoiled pBR322 were incubated with 25 nM topoisomerase VI for 4 min at 75 °C in the presence of 10 mM MgCl2 (lane 1-4) or 10 mM CaCl2 (lane 5-8). Reactions were stopped by the addition of 1% SDS (final concentration) followed by digestion with proteinase K. Lanes 1 and 5, control DNA whithout enzyme; lanes 3 and 7, incubation with 1 mM ATP; lanes 4 and 8, incubation with 1 mM AMP-PNP. After electrophoresis, the gel was stained with ethidium bromide. n, nicked DNA; l, linear DNA; s, supercoiled DNA.

Distribution of DNA Topoisomerase VI Double-strand Breaks on pBR322-- In order to analyze double-strand breaks distribution on pBR322, we labeled two linear fragments covering the entire plasmid sequence. The plasmid was first linearized with EcoRI and labeled at its 5'-ends using T4 polynucleotide kinase and [gamma -32P]ATP. This DNA was further digested with the restriction enzyme ScaI leading to two singly end-labeled fragments of 515-bp ("small") and 3848-bp ("large") (Fig. 4, panel A). Both DNA substrates were used in a standard DNA cleavage assay and the resulting cleaved molecules were separated by electrophoresis on a 1% agarose gel (Fig. 4, panel B) or a nondenaturing acrylamide gel (Fig. 4, panel C) for the small and large molecules, respectively. As previously observed with a supercoiled DNA substrate (see above), no DNA cleavage occurred in the absence of ATP on these linear DNA (Fig. 4, B, lane 2, and C, lane 2). TopoVI efficiently generates double-strand breaks at multiple sites when ATP is added to the reaction (Fig. 4, B, lane 3, and C, lane 3). Noteworthy, a strong topoVI cleavage site near the SspI restriction site of pBR322 is observed (Fig. 4C, compare lanes 3 and 5). The topoVI induced DNA breaks are different in efficiency, indicating that a limited sequence specificity does exist for the interaction of the enzyme with DNA. When using AMP-PNP instead of ATP, a slight increase in the efficiency of the double-strand cleavage is observed, with no variation in the overall cleavage pattern (Fig. 4, B, lane 4, and C, lane 4).


View larger version (21K):
[in this window]
[in a new window]
 
Fig. 4.   Distribution of DNA double-strand breaks catalyzed by topoisomerase VI on pBR322. A, drawing of linear DNA fragments used for the analysis of the distribution of topoVI cleavage sites on pBR322 (see "Experimental Procedures" for preparation of both substrates). The stars correspond to the 5'-ends labeled with 32P. B, agarose gel analysis of the distribution of topoVI cleavage sites on the large pBR322 DNA fragment. Lane 1, control DNA without enzyme; lanes 2-4, incubation with topoVI; lanes 3 and 4, incubation with 1 mM ATP and 1 mM AMP-PNP, respectively. C, nondenaturing acrylamide gel analysis of the distribution of topoVI cleavage sites on the small pBR322 DNA fragment. Lane 1, control DNA whithout enzyme; lanes 2-4, incubation with topoVI; lanes 3 and 4, incubation with 1 mM ATP and 1 mM AMP-PNP, respectively; lane 5, partial digestion of the small DNA fragment with SspI restriction enzyme producing a 195-bp fragment. After electrophoresis the gels were dried and exposed to PhosphorImager screen.

DNA Topoisomerase VI Is Covalently Linked to the 5'-Ends of the Cleaved DNA-- A common feature of type IIA DNA topoisomerases is a covalent fixation to the 5'-ends of the cleaved DNA via the active site tyrosine. Similar results were obtained for S. cerevisiae Spo11 protein which is also covalently attached to the 5'-ends of the meiotic double-strand breaks via a phosphotyrosine linkage (12, 27). In order to identify which strand is covalently linked to S. shibatae topoVI, we labeled the 515-bp linear fragment, either at its 5'- or 3'-end with 32P. These substrates were used in a standard DNA cleavage assay, and covalent fixation of the enzyme to the cleaved DNA was analyzed regarding further proteinase K treatment (Fig. 5). When 5'-end labeled DNA was used as a substrate, cleaved DNA fragments were recovered even in the absence of proteinase K treatment (Fig. 5, lanes 2 and 3). In contrast, when using a 3'-end-labeled DNA fragment, cleavage products enter the gel only after the proteolytic treatment (Fig. 5, compare lanes 5 and 6). Thus, similarly to type IIA DNA topoisomerase and Spo11, S. shibatae topoVI is covalently linked to the 5'-ends of the cleaved strands.


View larger version (35K):
[in this window]
[in a new window]
 
Fig. 5.   Topoisomerase VI is covalently linked to the 5'-ends of the cleavage sites. A 515-bp fragment (between EcoRI and ScaI sites on pBR322) was labeled with 32P at either its 5'- or 3'-end. These DNA fragments were used as substrates in a standard cleavage assay. The products were analyzed by electrophoresis on a 8% polyacrylamide, 8 M urea-sequencing gel. Lanes 1 and 4, control reaction without topoVI; lanes 2 and 5, incubation with topoVI followed by proteinase K treatment; lanes 3 and 6, incubation with topoVI without proteinase K treatment. After electrophoresis the gel was dried and exposed to PhosphorImager screen.

Sequence Analysis of DNA Topoisomerase VI Cleavage Sites-- The purification of a soluble and fully active recombinant topoVI offers the possibility to characterize in vitro the structure of the double-strand breaks generated by a member of the type IIB DNA topoisomerase family. The structure of several topoVI cleavage sites were analyzed by mapping the 3'-ends of the cleaved DNA fragments on each strands (named upper and lower strands). The precise length of these fragments were determined by comparison with an enzymatic sequencing of the initial DNA substrate (Fig. 6).


View larger version (80K):
[in this window]
[in a new window]
 
Fig. 6.   Sequence analysis of topoisomerase VI cleavage sites. A, a 529-bp fragment was labeled at its 5'-end and digested with ScaI (upper strand) or EcoRI (lower strand) restriction enzymes to generate singly end-labeled DNA. These substrates were used in a standard cleavage assay and the purified cleaved fragments were loaded onto sequencing gels along with sequencing reactions of their respective molecules. Lanes 1 and 4, purified DNA cleavage products; lanes 2 and 5, DNA cleavage product further treated with E. coli DNA polymerase I Klenow fragment; lanes 3 and 6, control reactions without topoVI.

We identified 19 detectable fragments on both strands (Fig. 6, lane 1 and lane 4, for the upper and lower strand, respectively). Noteworthy, we were able to map the strong topoVI cleavage site previously observed near the SspI restriction site. Comparison of the DNA breaks intensity on both strands suggests that they all correspond to each other. Moreover, since nearly all supercoiled pBR322 plasmids are linearized after SDS treatment in the presence of AMP-PNP and Ca2+ (see Fig. 2), these DNA cuts should correspond effectively to double-strand breaks and not to single-strand DNA cleavages. Interestingly, the precise resolution of all these breaks reveals that they are facing each other with a two-base stagger (Fig. 7).


View larger version (39K):
[in this window]
[in a new window]
 
Fig. 7.   Nucleotide position and relative intensities of topoisomerase VI double-strand cleavage sites on the 529-bp EcoRI-ScaI fragment of pBR322. Arrows indicate the mesured ends of cleaved molecules on both strands. The percentages given for all breaks have been estimated using ImageQuant software. White arrows correspond to DNA cleavages frequencies less than 3%, bold arrows to DNA cleavages greater than 5%. Numbers refer to the nucleotides of pBR322.

To further confirm this unusual structure, we used the purified cleaved fragments as substrates for the Klenow fragment of E. coli DNA polymerase I, as previously performed to characterized the structure of the double-strand breaks catalyzed by type IIA DNA topoisomerases (25, 26). We observed that all the cleaved DNA fragments were extended by two nucleotides for both strands (Fig. 6, lanes 2 and 5), confirming that topoVI effectively generates double-strand breaks with two-nucleotide overhangs.

Comparison of the sequences of these double-strand breaks revealed an additional feature unique for a type II DNA topoisomerase (see Fig. 7). 15 out of the 19 cleavage sites contain A and T nucleotides on their 5' protruding ends. Noteworthy, the four remaining cleavage sites (marked e, h, j, and o) correspond to minor cleavage sites. As for other type II DNA topoisomerases, no evident sequence similarities surrounding the cleavage site could be identified (2).

    DISCUSSION
TOP
ABSTRACT
INTRODUCTION
EXPERIMENTAL PROCEDURES
RESULTS
DISCUSSION
REFERENCES

In this work, we used a fully soluble form of recombinant S. shibatae topoVI to analyze the double-strand DNA cleavage mechanism, on both linear and negatively supercoiled DNA. This new recombinant enzyme was obtained by expressing the two topoVI subunits simultaneously in E. coli from a single vector. We had previously reported the reconstitution of S. shibatae topoVI from its separately purified subunits (Fig. 2) (23). However, in that case, the A subunit was recovered in inclusion bodies, and could only be solubilized after denaturation and renaturation, raising the possibility that some data obtained with the renatured enzyme could have been misleading. The coexpression of the two subunit genes in tandem might be important for the in vivo reconstitution of the heterotetramer in a soluble form. It should be noticed that the two genes encoding topoVI subunits are indeed organized in tandem in several archaeal genomes, including S. shibatae.

DNA double-strand cleavage is a key step in the catalytic mechanism of type II DNA topoisomerase. We report here two major differences of the DNA cleavage reaction between both families of type II DNA topoisomerases. 1) ATP is absolutely required for the DNA cleavage reaction by topoVI (Figs. 3 and 4). 2) TopoVI cleavage sites are all characterized by staggered two-nucleotide long 5' protruding ends, instead of four-nucleotide overhangs previously observed for type IIA DNA topoisomerase cleavage sites (Fig. 6).

The strict requirement of either ATP or its nonhydrolyzable analog AMP-PNP for trapping topoVI cleavable complexes is unique among type II DNA topoisomerases since several reports indicate that ATP is not required in the DNA cleavage reactions catalyzed by type IIA enzymes. (i) DNA gyrase is able to relax a negatively supercoiled DNA in the absence of ATP (31). (ii) Eucaryotic topoII, or truncated enzymes lacking the ATPase binding/hydrolyzing domain, are still able to cleave DNA in the absence of ATP (4, 18). (iii) Finally, analysis of E. coli DNA topoIV activities indicates also an ATP independent DNA cleavage reaction (24).

The recent crystallographic structure of the DNA-binding core of the M. jannashii topoVI A subunit has revealed that a Rossman-fold like domain, which coordinates a magnesium ion through conserved acidic residues, lies next to the active site tyrosine, itself located whithin a CAP-like DNA-binding domain (21). Therefore the topoVI A subunit possesses, by itself, all the functional domains required for DNA cleavage by type IIA DNA topoisomerases (B' plus A' domain, see Fig. 1). However, since no cleavage activity using the S. shibatae topoVI A subunit alone has been detected (23), these functionnal domains do not seem to be sufficient to generate DNA cleavage, at least not in the case of this enzyme. The data presented here indeed support the idea that topoVI-induced DNA cleavage requires the cooperation of both A and B subunits, since this cleavage is strictly ATP dependent and the ATP-binding site of topoVI is located on the B subunit.

The modeling of a DNA duplex into the TopoVIA' dimer DNA binding groove, showed that the CAP-like domains lie too far from the DNA backbone to cleave and generate a phosphotyrosine linkage (21). Therefore, a conformational change of the topoVI A subunits seems to be required to cleave the DNA backbone. Our results thus strongly suggest that the B subunit could induce this change (through ATP binding), shifting the catalytic domains into proper orientation to cut DNA. In the absence of ATP, the A subunit dimer conformation in the whole enzyme could be similar to the structure obtained for the M. jannashii topoVI-A' dimer.

A "two-gate model," in which a transported DNA segment enters and exits from two opposite sides of the enzyme, has been proposed for both subfamilies of type II DNA topoisomerases (2, 21, 32). While the transported duplex can be stored within the A' domain of type IIA DNA topoisomerases, the topoVI-A' dimer lacks such a storage area. As a consequence, to allow the crossing of the two DNA segments, a DNA gate should be created by dissociation of the topoVI-A dimer, after covalent fixation to the 5'-ends of the broken DNA segment. In this model, as well as capturing the DNA segment to be transported, the assigned function of B subunits should be to hold the separated A subunits in order to avoid enzyme dissociation and subsequent generation of free double-strand breaks (enzyme-bridging mechanism) (21, 23). Assuming that the B subunits dimerize after ATP binding, the strict ATP-dependent DNA cleavage presented in this study is in good agreement with this model.

While our results on the DNA cleavage reaction catalyzed by S. shibatae topoVI highlight a direct implication of the B subunit in this reaction, it should be reminded that no partner of the meiotic double-strand break effector Spo11 has been yet identified in the complete sequenced genome of S. cerevisiae and C. elegans. Therefore, even though Spo11 carries all the catalytic domains directly involved in the formation of a double-strand break, our analysis suggests that a partner could be required to stabilize Spo11 in a conformation suitable for DNA cleavage.

In the present study, the structure of the topoVI cleavage complex has been further characterized. We observed that topoVI is covalently attached to the 5'-ends of the cleaved strands (Fig. 5), consistent with the fixation of S. cerevisiae Spo11 to the 5'-ends of meiotic double-strand breaks (12, 27). Sequence determination of topoVI induced double-strand breaks reveals an unusual feature for a type II DNA topoisomerase. All breaks are characterized by staggered two-nucleotide long 5' protruding ends (Fig. 6), while earlier studies of the double-strand breaks generated by type IIA DNA topoisomerases revealed four-nucleotide overhangs (25, 26). On the other hand, contrasting results were obtained from in vivo analysis of the double-strand breaks structure induced by Spo11 during meiosis. While these breaks are characterized by two-nucleotide 5' overhangs in the ARG4 promoter region (33), blunt DNA ends were observed in the CYS3 promoter region or upstream of the HIS4 gene (34, 35). However, since these analysis were performed in vivo, from a rad50S mutant in which meiotic double-strand breaks persist, these blunt structures could reflect filling in of the 3' ends by the cellular repair machinery.4

The sequence determination and mapping of the topoVI-induced double-strand breaks revealed another feature unique among type II DNA topoisomerases. Whereas cleavage efficiency differs from site to site, their 5' extensions are mainly composed of A and T nucleotides (Fig. 7). Interestingly, A and T nucleotides have also been found in the 5' overhangs of the most prominent double-strand break generated by Spo11 protein in the ARG4 promoter region (33). While no obvious consensus sequence have been described for type IIA enzymes (2), the high occurrence of these nucleotides in the 5' extensions generated by topoVI could represent a first insight in a preferred sequence recognized by a type IIB DNA topoisomerases.

While studies on the catalytic mechanism by type IIB DNA topoisomerases are still in their infancy, this study highlights unusual features for a type II DNA topoisomerase both on formation and structure of the cleavage complex. Moreover the strict requirement of both topoVI subunits in DNA cleavage catalysis would suggest that the eucaryotic Spo11 protein should be somehow assisted to generate the meiotic double-strand breaks

    ACKNOWLEDGEMENTS

We thank A. Bergerat, S. Knapp, and C. Elie for helpful discussions and comments on the manuscript.

    FOOTNOTES

* This work was supported by grants from the Association pour la Recherche sur le Cancer.The costs of publication of this article were defrayed in part by the payment of page charges. The article must therefore be hereby marked "advertisement" in accordance with 18 U.S.C. Section 1734 solely to indicate this fact.

§ To whom correspondence should be addressed. Tel.: 33-1-69-15-64-48; Fax: 33-1-69-15-78-08; E-mail: cyril.buhler@igmors.u-psud.fr.

Published, JBC Papers in Press, August 2, 2001, DOI 10.1074/jbc.M101823200

2 C. Buhler, unpublished observation.

3 CAP designates the DNA-binding domain of the E. coli catabolite activator protein.

4 B. de Massy, personal communication.

    ABBREVIATIONS

The abbreviations used are: topoVI, DNA topoisomerase VI; topoII, DNA topoisomerase II; topoIV, DNA topoisomerase IV; DTT, dithiothreitol; AMP-PNP, adenosine 5'-(beta ,gamma -imino)triphosphate; bp, base pair(s).

    REFERENCES
TOP
ABSTRACT
INTRODUCTION
EXPERIMENTAL PROCEDURES
RESULTS
DISCUSSION
REFERENCES

1. Wang, J. C. (1998) Q. Rev. Biophys. 31, 107-144
2. Wang, J. C. (1996) Annu. Rev. Biochem. 65, 635-692
3. Bergerat, A., de Massy, B., Gadelle, D., Varoutas, P. C., Nicolas, A., and Forterre, P. (1997) Nature 386, 414-417
4. Berger, J. M., Gamblin, S. J., Harrison, S. C., and Wang, J. C. (1996) Nature 379, 225-232
5. Fass, D., Bogden, C. E., and Berger, J. M. (1999) Nat. Struct. Biol. 6, 322-326
6. Morais Cabral, J. H., Jackson, A. P., Smith, C. V., Shikotra, N., Maxwell, A., and Liddington, R. C. (1997) Nature 388, 903-906
7. Wigley, D. B., Davies, G. J., Dodson, E. J., Maxwell, A., and Dodson, G. (1991) Nature 351, 624-629
8. Bergerat, A., Gadelle, D., and Forterre, P. (1994) J. Biol. Chem. 269, 27663-27669
9. Dutta, R., and Inouye, M. (2000) Trends Biochem. Sci. 25, 24-28
10. Smith, K. N., and Nicolas, A. (1998) Curr. Opin. Genet. Dev. 8, 200-211
11. Paques, F., and Haber, J. E. (1999) Microbiol. Mol. Biol. Rev. 63, 349-404
12. Keeney, S., Giroux, C. N., and Kleckner, N. (1997) Cell 88, 375-384
13. Ng, W. V., Kennedy, S. P., Mahairas, G. G., Berquist, B., Pan, M., Shukla, H. D., Lasky, S. R., Baliga, N. S., Thorsson, V., Sbrogna, J., Swartzell, S., Weir, D., Hall, J., Dahl, T. A., Welti, R., Goo, Y. A., Leithauser, B., Keller, K., Cruz, R., Danson, M. J., Hough, D. W., Maddocks, D. G., Jablonski, P. E., Krebs, M. P., Angevine, C. M., Dale, H., Isenbarger, T. A., Peck, R. F., Pohlschroder, M., Spudich, J. L., Jung, K. W., Alam, M., Freitas, T., Hou, S., Daniels, C. J., Dennis, P. P., Omer, A. D., Ebhardt, H., Lowe, T. M., Liang, P., Riley, M., Hood, L., and DasSarma, S. (2000) Proc. Natl. Acad. Sci. U. S. A. 97, 12176-12181
14. Hartung, F., and Puchta, H. (2000) Nucleic Acids Res. 28, 1548-1554
15. Shannon, M., Richardson, L., Christian, A., Handel, M. A., and Thelen, M. P. (1999) FEBS Lett. 462, 329-334
16. Grelon, M., Vezon, D., Gendrot, G., and Pelletier, G. (2001) EMBO J. 20, 589-600
17. Brown, P. O., Peebles, C. L., and Cozzarelli, N. R. (1979) Proc. Natl. Acad. Sci. U. S. A. 76, 6110-6119
18. Gellert, M., Fisher, L. M., and O'Dea, M. H. (1979) Proc. Natl. Acad. Sci. U. S. A. 76, 6289-6293
19. Berger, J. M., Fass, D., Wang, J. C., and Harrison, S. C. (1998) Proc. Natl. Acad. Sci. U. S. A. 95, 7876-7881
20. Aravind, L., Leipe, D. D., and Koonin, E. V. (1998) Nucleic Acids Res. 26, 4205-4213
21. Nichols, M. D., DeAngelis, K., Keck, J. L., and Berger, J. M. (1999) EMBO J. 18, 6177-6188
22. Liu, Q., and Wang, J. C. (1999) Proc. Natl. Acad. Sci. U. S. A. 96, 881-886
23. Buhler, C., Gadelle, D., Forterre, P., Wang, J. C., and Bergerat, A. (1998) Nucleic Acids Res. 26, 5157-5162
24. Kato, J., Suzuki, H., and Ikeda, H. (1992) J. Biol. Chem. 267, 25676-25684
25. Morrison, A., and Cozzarelli, N. R. (1979) Cell 17, 175-184
26. Sander, M., and Hsieh, T. (1983) J. Biol. Chem. 258, 8421-8428
27. Keeney, S., and Kleckner, N. (1995) Proc. Natl. Acad. Sci. U. S. A. 92, 11274-11278
28. Stoscheck, C. M. (1990) Methods Enzymol. 182, 50-68
29. Osheroff, N., and Zechiedrich, E. L. (1987) Biochemistry 264, 303-4309
30. Lee, M. P., Sander, M., and Hsieh, T. S. (1989) J. Biol. Chem. 264, 13510-13518
31. Reece, R. J., and Maxwell, A. (1991) Crit. Rev. Biochem. Mol. Biol. 26, 335-375
32. Roca, J., and Wang, J. C. (1994) Cell 77, 609-616
33. Liu, J., Wu, T. C., and Lichten, M. (1995) EMBO J. 14, 4599-4608
34. de Massy, B., Rocco, V., and Nicolas, A. (1995) EMBO J. 14, 4589-4598
35. Xu, F., and Petes, T. D. (1996) Genetics 143, 1115-1125
36. Worland, S. T., and Wang, J. C. (1989) J. Biol. Chem. 264, 4412-4416


Copyright © 2001 by The American Society for Biochemistry and Molecular Biology, Inc.
Add to CiteULike CiteULike   Add to Complore Complore   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati    What's this?


This article has been cited by other articles:


Home page
Nucleic Acids ResHome page
D. Gadelle, C. Bocs, M. Graille, and P. Forterre
Inhibition of archaeal growth and DNA topoisomerase VI activities by the Hsp90 inhibitor radicicol
Nucleic Acids Res., April 22, 2005; 33(7): 2310 - 2317.
[Abstract] [Full Text] [PDF]


Home page
J. Bacteriol.Home page
D. W. Grogan and J. E. Hansen
Molecular Characteristics of Spontaneous Deletions in the Hyperthermophilic Archaeon Sulfolobus acidocaldarius
J. Bacteriol., February 15, 2003; 185(4): 1266 - 1272.
[Abstract] [Full Text] [PDF]


This Article
Right arrow Abstract Freely available
Right arrow Full Text (PDF)
Right arrow All Versions of this Article:
276/40/37215    most recent
M101823200v1
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Buhler, C.
Right arrow Articles by Forterre, P.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Buhler, C.
Right arrow Articles by Forterre, P.
Social Bookmarking
 Add to CiteULike   Add to Complore   Add to Connotea   Add to Del.icio.us   Add to Digg   Add to Reddit   Add to Technorati  
What's this?


HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS